FSD Pharma Inc (CNSX:HUGE) Director Buys $13,300.00 in Stock

FSD Pharma Inc (CNSX:HUGEGet Rating) Director Donal Carroll bought 10,000 shares of the firm’s stock in a transaction that occurred on Thursday, April 14th. The stock was bought at an average price of $1.33 per share, with a total value of $13,300.00. Following the transaction, the director now directly owns 122,957 shares in the company, valued at $163,532.81.

About FSD Pharma (Get Rating)

FSD Pharma Inc operates as a cannabis company in Canada. It is involved in hydroponic indoor cannabis production and processing activities. The company, through its subsidiary, FV Pharma Inc, holds license to produce marijuana under the Access to Cannabis for Medical Purposes Regulations. It has a strategic alliance agreement with SciCann Therapeutics Inc for the production and distribution of cannabinoid-based, patent pending, and indication-specific products developed by SciCann Therapeutics Inc The company was formerly known as Century Financial Capital Group Inc and changed its name to FSD Pharma Inc in May 2018.

Further Reading

Receive News & Ratings for FSD Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FSD Pharma and related companies with MarketBeat.com's FREE daily email newsletter.